SK Plasma

SK Plasma Co., Ltd. is a South Korean company specializing in the production of plasma-derived products aimed at treating various medical conditions, including hypoalbuminemia, hemorrhagic shock, antithrombin deficiency, and tetanus. Established in 2015 and based in Seongnam-si, the company focuses on developing high-quality plasma derivatives that serve as essential medicines for conditions such as congenital immunodeficiency diseases and hemophilia. SK Plasma has gained a strong reputation in the export market, reflecting its commitment to enhancing human health and ensuring safety through its innovative products. As a subsidiary of SK Chemicals Co., Ltd., SK Plasma leverages its parent company's expertise while concentrating on its core competencies in plasma derivatives to provide effective solutions for healthcare professionals and patients alike.